316 related articles for article (PubMed ID: 10647060)
1. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding.
Kobayashi K; Forte TM; Taniguchi S; Ishida BY; Oka K; Chan L
Metabolism; 2000 Jan; 49(1):22-31. PubMed ID: 10647060
[TBL] [Abstract][Full Text] [Related]
2. Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice. Effects on lipoproteins and atherosclerosis.
Kako Y; Huang LS; Yang J; Katopodis T; Ramakrishnan R; Goldberg IJ
J Lipid Res; 1999 Dec; 40(12):2185-94. PubMed ID: 10588944
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
[TBL] [Abstract][Full Text] [Related]
5. Streptozotocin-Treated High Fat Fed Mice: A New Type 2 Diabetes Model Used to Study Canagliflozin-Induced Alterations in Lipids and Lipoproteins.
Yu T; Sungelo MJ; Goldberg IJ; Wang H; Eckel RH
Horm Metab Res; 2017 May; 49(5):400-406. PubMed ID: 28395380
[TBL] [Abstract][Full Text] [Related]
6. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet.
Dixon JL; Stoops JD; Parker JL; Laughlin MH; Weisman GA; Sturek M
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2981-92. PubMed ID: 10591679
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.
Pontrelli L; Parris W; Adeli K; Cheung RC
Metabolism; 2002 Mar; 51(3):334-42. PubMed ID: 11887170
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E-containing lipoproteins and lipoprotein remnants in experimental canine diabetes.
Wilson DE; Chan IF; Elstad NL; Peric-Golia L; Hejazi J; Albu DS; Cutfield R
Diabetes; 1986 Aug; 35(8):933-42. PubMed ID: 3732634
[TBL] [Abstract][Full Text] [Related]
9. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
Kockx M; Glaros E; Leung B; Ng TW; Berbée JF; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PC; Meikle PJ; Kritharides L
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1338-49. PubMed ID: 27150391
[TBL] [Abstract][Full Text] [Related]
10. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.
Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS
Diabetes; 2008 Jun; 57(6):1674-82. PubMed ID: 18346984
[TBL] [Abstract][Full Text] [Related]
11. Serum lipoprotein and apolipoprotein profiles of the genetically obese ob/ob mouse.
Camus MC; Aubert R; Bourgeois F; Herzog J; Alexiu A; Lemonnier D
Biochim Biophys Acta; 1988 Jul; 961(1):53-64. PubMed ID: 3382693
[TBL] [Abstract][Full Text] [Related]
12. Osbpl8 deficiency in mouse causes an elevation of high-density lipoproteins and gender-specific alterations of lipid metabolism.
Béaslas O; Metso J; Nissilä E; Laurila PP; Kaiharju E; Batchu KC; Kaipiainen L; Mäyränpää MI; Yan D; Gylling H; Jauhiainen M; Olkkonen VM
PLoS One; 2013; 8(3):e58856. PubMed ID: 23554939
[TBL] [Abstract][Full Text] [Related]
13. The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.
Diabetes Atorvastin Lipid Intervention (DALI) Study Group
Diabetes Care; 2001 Aug; 24(8):1335-41. PubMed ID: 11473066
[TBL] [Abstract][Full Text] [Related]
14. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
[TBL] [Abstract][Full Text] [Related]
15. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
16. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.
Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP
Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863
[TBL] [Abstract][Full Text] [Related]
17. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
Nikkilä EA; Huttunen JK; Ehnholm C
Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
[TBL] [Abstract][Full Text] [Related]
18. Diabetic dyslipidemia.
Kreisberg RA
Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
[TBL] [Abstract][Full Text] [Related]
19. [On the etiology of diabetic hyperlipidemia from the aspects of the metabolism of ApoHDL (author's transl)].
Keimatsu M
Hokkaido Igaku Zasshi; 1981 Sep; 56(5):557-69. PubMed ID: 7319464
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels.
Cominacini L; Garbin U; Davoli A; Campagnola M; De Santis A; Pasini C; Pastorino AM; Bosello O
Ann Nutr Metab; 1993; 37(4):175-84. PubMed ID: 8215234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
